Clinical Trials Logo

Filter by:
NCT ID: NCT06295965 Recruiting - Clinical trials for Recurrent Ovarian Carcinoma

Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers

Start date: January 2, 2024
Phase:
Study type: Observational

This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancers. Researchers want to identify risk factors for developing these blood cancers as well as if there is/are a genetic/environmental component(s) to developing blood cancer.

NCT ID: NCT06295952 Recruiting - Clinical trials for Prolactin-Producing Pituitary Tumor

A Study of Pasireotide in People With Prolactinoma

Start date: February 27, 2024
Phase: Phase 2
Study type: Interventional

The researchers are doing this study to find out whether pasireotide is an effective treatment for people with prolactinoma who cannot receive dopamine agonist therapy. Another purpose of this study is to find out whether pasireotide is a safe treatment for people with prolactinoma.

NCT ID: NCT06295783 Active, not recruiting - Radiation Clinical Trials

Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect

Start date: June 10, 2024
Phase:
Study type: Observational

To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.

NCT ID: NCT06295770 Recruiting - Clinical trials for Fibrillary Glomerulonephritis

Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

Start date: June 24, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this research is to learn if Obinutuzumab is effective and safe in treating patients with fibrillary glomerulonephritis (FGN).

NCT ID: NCT06295744 Recruiting - Clinical trials for Early-stage Breast Cancer

Outcomes and Cosmesis With Whole Breast Irradiation and Boost

Start date: April 17, 2024
Phase: N/A
Study type: Interventional

This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.

NCT ID: NCT06295731 Recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma (HNSCC)

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Start date: May 14, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody INBRX-106 combined with the anti-PD-1 antibody pembrolizumab versus pembrolizumab (+ placebo in phase 3) as first-line treatment for patients with locally advanced recurrent or metastatic head and neck squamous cell carcinoma (R/M HSNSCC) incurable by local therapies, expressing PD-L1 with a combined proportion score (CPS) ≥20.

NCT ID: NCT06295705 Recruiting - Clinical trials for Autism Spectrum Disorder

Exploring the Effectiveness of Dance as an Intervention to Promote Social-Emotional Health in Children With Autism Spectrum Disorder (ASD)

ASD
Start date: April 2, 2024
Phase: N/A
Study type: Interventional

This study will explore the effectiveness of dance as an intervention to promote social-emotional health within children with ASD.

NCT ID: NCT06295588 Not yet recruiting - Inflammation Clinical Trials

Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

Start date: July 15, 2024
Phase: N/A
Study type: Interventional

To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation.

NCT ID: NCT06295523 Recruiting - Aging Clinical Trials

Heat Waves and the Elderly With COPD

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate thermoregulatory responses in older individuals with COPD.

NCT ID: NCT06295471 Not yet recruiting - Healthy Clinical Trials

A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a DFG Laser and CO2 Laser

Start date: July 2024
Phase: N/A
Study type: Interventional

This research study aims assess whether the Difference Frequency Generation (DFG) laser could be a better alternative to the CO2 laser in terms of reduced side effects and patient downtime.